BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24907358)

  • 1. Genetic characterization of acquired aplastic anemia by targeted sequencing.
    Heuser M; Schlarmann C; Dobbernack V; Panagiota V; Wiehlmann L; Walter C; Beier F; Ziegler P; Yun H; Kade S; Kirchner A; Huang L; Koenecke C; Eder M; Brümmendorf TH; Dugas M; Ganser A; Thol F
    Haematologica; 2014 Sep; 99(9):e165-7. PubMed ID: 24907358
    [No Abstract]   [Full Text] [Related]  

  • 2. Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome.
    Kulasekararaj AG; Jiang J; Smith AE; Mohamedali AM; Mian S; Gandhi S; Gaken J; Czepulkowski B; Marsh JC; Mufti GJ
    Blood; 2014 Oct; 124(17):2698-704. PubMed ID: 25139356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia.
    Dumitriu B; Feng X; Townsley DM; Ueda Y; Yoshizato T; Calado RT; Yang Y; Wakabayashi Y; Kajigaya S; Ogawa S; Zhu J; Young NS
    Blood; 2015 Jan; 125(4):706-9. PubMed ID: 25406353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria.
    Sun L; Babushok DV
    Blood; 2020 Jul; 136(1):36-49. PubMed ID: 32430502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of ASXL1 and TET2 in aplastic anemia.
    Huang J; Ge M; Lu S; Shi J; Li X; Zhang J; Wang M; Yu W; Shao Y; Huang Z; Zhang J; Nie N; Zheng Y
    Haematologica; 2015 May; 100(5):e172-5. PubMed ID: 25596262
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients.
    Keel SB; Scott A; Sanchez-Bonilla M; Ho PA; Gulsuner S; Pritchard CC; Abkowitz JL; King MC; Walsh T; Shimamura A
    Haematologica; 2016 Nov; 101(11):1343-1350. PubMed ID: 27418648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelodysplastic syndromes: lost between two states?
    Acquaviva C; Gelsi-Boyer V; Birnbaum D
    Leukemia; 2010 Jan; 24(1):1-5. PubMed ID: 20068572
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study on HFE gene mutations in patients with myelodysplastic syndromes and aplastic anemia].
    Nie L; Ai XF; Zheng YZ; Li QH; Yang L; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):223-8. PubMed ID: 19731820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origins of myelodysplastic syndromes after aplastic anemia.
    Negoro E; Nagata Y; Clemente MJ; Hosono N; Shen W; Nazha A; Yoshizato T; Hirsch C; Przychodzen B; Mahfouz RZ; Kuzmanovic T; Sekeres MA; Makishima H; Ogawa S; Maciejewski JP
    Blood; 2017 Oct; 130(17):1953-1957. PubMed ID: 28893734
    [No Abstract]   [Full Text] [Related]  

  • 10. Evolution of clonal dynamics and differential response to targeted therapy in a case of systemic mastocytosis with associated myelodysplastic syndrome.
    Yun HD; Antony ML; Linden MA; Noble-Orcutt KE; Eckfeldt CE; Ustun C; Nelson AC; Sachs Z
    Leuk Res; 2020 Aug; 95():106404. PubMed ID: 32569927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two cases showing clonal progression with full evolution from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome to myelodysplastic syndromes and leukemia.
    Ishihara S; Nakakuma H; Kawaguchi T; Nagakura S; Horikawa K; Hidaka M; Asou N; Mitsuya H
    Int J Hematol; 2000 Aug; 72(2):206-9. PubMed ID: 11039670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.
    Faivre L; Guardiola P; Lewis C; Dokal I; Ebell W; Zatterale A; Altay C; Poole J; Stones D; Kwee ML; van Weel-Sipman M; Havenga C; Morgan N; de Winter J; Digweed M; Savoia A; Pronk J; de Ravel T; Jansen S; Joenje H; Gluckman E; Mathew CG
    Blood; 2000 Dec; 96(13):4064-70. PubMed ID: 11110674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-Generation Gene Sequencing Differentiates Hypoplastic Myelodysplastic Syndrome from Aplastic Anemia.
    Lew JL; Fenderson JL; Carmichael MG
    Hawaii J Med Public Health; 2017 Nov; 76(11 Suppl 2):10-12. PubMed ID: 29164009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive telomere shortening in aplastic anemia.
    Ball SE; Gibson FM; Rizzo S; Tooze JA; Marsh JC; Gordon-Smith EC
    Blood; 1998 May; 91(10):3582-92. PubMed ID: 9572992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline variants drive myelodysplastic syndrome in young adults.
    Feurstein S; Churpek JE; Walsh T; Keel S; Hakkarainen M; Schroeder T; Germing U; Geyh S; Heuser M; Thol F; Pohlkamp C; Haferlach T; Gao J; Owen C; Goehring G; Schlegelberger B; Verma D; Krause DS; Gao G; Cronin T; Gulsuner S; Lee M; Pritchard CC; Subramanian HP; Del Gaudio D; Li Z; Das S; Kilpivaara O; Wartiovaara-Kautto U; Wang ES; Griffiths EA; Döhner K; Döhner H; King MC; Godley LA
    Leukemia; 2021 Aug; 35(8):2439-2444. PubMed ID: 33510405
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular Testing in Patients with Suspected Myelodysplastic Syndromes.
    Moyo TK; Savona MR
    Curr Hematol Malig Rep; 2016 Dec; 11(6):441-448. PubMed ID: 27734261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMML.
    Schuler E; Frank F; Hildebrandt B; Betz B; Strupp C; Rudelius M; Aul C; Schroeder T; Gattermann N; Haas R; Germing U
    Leuk Res; 2018 Feb; 65():1-4. PubMed ID: 29216536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
    Maciejewski JP; Risitano A; Sloand EM; Nunez O; Young NS
    Blood; 2002 May; 99(9):3129-35. PubMed ID: 11964274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-RAS gene mutation in patients with aplastic anemia and aplastic anemia/ paroxysmal nocturnal hemoglobinuria during evolution to clonal disease.
    Mortazavi Y; Tooze JA; Gordon-Smith EC; Rutherford TR
    Blood; 2000 Jan; 95(2):646-50. PubMed ID: 10627475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SWI/SNF subunit expression heterogeneity in human aplastic anemia stem/progenitors.
    Sinha S; Chatterjee SS; Biswas M; Nag A; Banerjee D; De R; Sengupta A
    Exp Hematol; 2018 Jun; 62():39-44.e2. PubMed ID: 29596882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.